COVID-19: ‘Cicada’ Variant BA.3.2 Spreads in US – Symptoms & Updates 2026

The news coming out of the CDC and reported by outlets like TODAY.com and USA Today about the “Cicada” COVID-19 variant – officially BA.3.2 – is understandably causing a ripple of concern. Even as the overall risk level remains relatively low compared to previous surges, the fact that this highly mutated strain has been detected in over 25 states, including a significant number along the East Coast, warrants a closer look, especially here in the Philadelphia metropolitan area. It’s not about panic, but about informed preparedness, and understanding how this evolving virus might impact our community.

Understanding the BA.3.2 Variant: What Makes “Cicada” Different?

What’s grabbing the attention of epidemiologists isn’t necessarily the severity of illness caused by BA.3.2, but its genetic makeup. As highlighted in reports from Northeastern Global News, this variant boasts a substantial number of mutations – between 70 and 75 in the spike protein – a figure that’s raising eyebrows. This level of mutation raises the possibility of increased immune evasion, meaning prior infections or vaccinations might offer less protection against symptomatic illness. However, experts like those at the Mount Sinai hospital, as cited by NBC News, emphasize that current vaccines still provide significant protection against severe disease, hospitalization, and death.

The variant was first identified in a traveler arriving in San Francisco from the Netherlands in June 2025, and has since been tracked through genomic surveillance and wastewater analysis. The CDC and the World Health Organization (WHO) have classified BA.3.2 as a “variant under monitoring,” a designation that signals the need for continued vigilance. It’s vital to remember that the landscape of COVID-19 is constantly shifting, with new lineages like JN.1 and LP.8.1 having dominated circulation in 2024 and early 2025. The emergence of “Cicada” simply adds another layer to this ongoing evolution.

Symptoms of BA.3.2: What to Watch For in Philadelphia

Fortunately, the symptoms associated with BA.3.2 appear to be largely consistent with those of other COVID-19 variants. The CDC reports the most common signs include a dry or productive cough, fever or chills, sore throat, nasal congestion, difficulty breathing, loss of taste or smell, fatigue, headache, and gastrointestinal issues like nausea and diarrhea. These symptoms are familiar to most of us at this point, and it’s crucial to remember that they can overlap with other respiratory illnesses, such as influenza or the common cold. If you’re experiencing these symptoms, especially during peak cold and flu season, it’s wise to consider getting tested to determine the cause.

Here in Philadelphia, we have several convenient testing options available. Resources like the Philadelphia Department of Public Health website (phila.gov/public-health) provide up-to-date information on testing locations and at-home test kit availability. Many local pharmacies, including those within the CVS and Walgreens chains, offer COVID-19 testing services.

BA.3.2 in the United States: Where Has It Been Detected?

As of the latest reports, BA.3.2 has been detected in a wide range of states, including California, New York, Florida, Texas, Ohio, Pennsylvania, Massachusetts, New Jersey, Virginia, and several others. Pennsylvania, and specifically the Philadelphia region, is among the areas where the variant has been identified through wastewater surveillance programs like WastewaterSCAN, a collaborative effort involving the University of Stanford. While the variant currently represents a relatively small percentage of overall cases – less than 5% nationally – its presence underscores the importance of ongoing monitoring.

Impact on Vaccine Effectiveness and Future Outlook

While current vaccines may exhibit slightly reduced effectiveness against symptomatic infection with BA.3.2, they continue to provide robust protection against severe illness. Experts at NYU Langone Health, like Dana Mazo, emphasize that vaccination remains the best defense, particularly for vulnerable populations. The CDC recommends that everyone stay up-to-date with their COVID-19 vaccinations, including the updated 2025-2026 boosters designed to target recent variants.

Looking ahead, the evolution of the virus remains uncertain. The CDC and WHO are continuously monitoring BA.3.2 and other emerging variants to assess their potential impact on public health. It’s possible that future vaccine formulations will be adjusted to provide even greater protection against new strains. The key is to remain vigilant, informed, and proactive in protecting ourselves and our community.

Navigating BA.3.2 in Philadelphia: A Local Resource Guide

Given my background in public health and risk assessment, and considering the potential impact of this evolving variant on our community here in Philadelphia, I want to highlight three types of local professionals who can provide valuable support if you’re concerned about COVID-19 or experiencing symptoms. It’s about having a plan and knowing where to turn for reliable guidance.

1. Independent Primary Care Physicians:

Look for a physician with a strong focus on preventative care and a commitment to staying up-to-date on the latest COVID-19 guidance. A good practice will offer telehealth appointments for initial assessments and clear protocols for in-person testing and treatment. Consider practices affiliated with local hospital systems like Penn Medicine or Jefferson Health for seamless care coordination.

2. Occupational Health and Safety Consultants:

For businesses and organizations in the Philadelphia area, particularly those with frontline workers, an occupational health consultant can provide expert advice on implementing effective COVID-19 prevention strategies. Look for consultants certified by organizations like the Board of Certified Safety Professionals (BCSP) and experienced in navigating Pennsylvania’s workplace safety regulations.

3. Mental Health Professionals Specializing in Anxiety & Pandemic-Related Stress:

The ongoing pandemic has taken a toll on mental health. If you’re experiencing anxiety, stress, or other emotional challenges related to COVID-19, seeking support from a qualified mental health professional is crucial. Look for therapists licensed in Pennsylvania with experience in trauma-informed care and a focus on pandemic-related anxieties. Resources like the Philadelphia Mental Health Partnership can help you uncover a provider.

Ready to find trusted professionals? Browse our complete directory of top-rated health experts in the Philadelphia area today.